Alzheimer’s disease

What is Donanemab?

Alzheimer’s disease, a debilitating neurodegenerative disorder, has long posed challenges for medical professionals and researchers. However, recent developments...

📅 July 18, 2023

Abnormality of Astrocytes and Alzheimer’s Disease

Despite the availability of new drugs for treating early Alzheimer’s, predicting who will eventually develop the disease remains...

📅 June 1, 2023

Lecanemab Approved for Alzheimer’s Treatment

The US Food and Drug Administration (FDA) has approved lecanemab, a monoclonal antibody developed by Eisai and Biogen,...

📅 January 9, 2023

September 21: World Alzheimer’s Day

World Alzheimer Day was observed across the world on September 21 with the objective of raising awareness of...

📅 September 22, 2021

Alzheimer Inhibitor developed by Jawaharlal Nehru Centre of Advanced Scientific Research

The scientists of Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) operating under Department of Science and Technology...

📅 April 29, 2020

IIIT Hyderabad’s researchers creates first-ever ‘Indian Brain Atlas (IBA)’

The researchers at the International Institute of Information Technology-Hyderabad (IIITH) have created the first ever Indian Brain Atlas...

📅 October 31, 2019

Sleep Deprivation and Alzheimer's Risk

The study published by the Researchers of the Washington University of the US published in the journal Science...

📅 February 2, 2019

World Alzheimer’s Day observed globally

September 21 is World Alzheimer’s Day. The day is observed to spread awareness about Alzheimer’s disease across the...

📅 September 24, 2012